Merck & Co., US58933Y1055

Merck stock heads into the open after a 0.3 percent slip

Published on 09/21/2026 at 09:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 19, 2026, Merck stock finished at USD 146.63 on the New York Stock Exchange, down 0.3 percent. The shares traded between USD 145.74 and USD 147.84 and remained about 6.6 percent below the 52-week high.

Photorealistic wide-angle view of a modern oncology research laboratory. A scientist in white lab coat examines cancer cell slides under a fluorescence microscope. Amber glass vials with pharmaceutical compounds line the stainless steel bench. Biosafety c
Merck US58933Y1055 Onkologie-Labor: Wissenschaftler am Mikroskop analysiert Krebszellen, mehrere Wirkstoff-Vials stehen auf der Werkbank, Illustration mit AI erstellt.

Merck stock closed at USD 146.63 on the New York Stock Exchange on September 19, 2026, down 0.3 percent. The move left Merck & Co. Inc. (ISIN US58933Y1055) trading about 6.6 percent below its 52-week high of USD 156.92.

September 19, 2026 in numbers

The shares moved between USD 145.74 and USD 147.84 during the session and ended near the upper half of that range. A retail brokerage quote page showed the same close and put Merck's market value at USD 362.11 billion.

Broad market sentiment was firmer, with the S&P 500 ending the session at 7,650.50, up 0.17 percent. That left Merck below the index on the day, even as health care names were mixed in the broader tape.

Today after the launch

On September 18, 2026, Merck said it launched Merck 'Your Hive of Whole Health' and said the program will be featured at USCHA. That event remains the main company-specific item tied to today's session. Brent crude futures also fell on Monday morning, a market move that can matter for health care risk appetite, according to Reuters.

Disclaimer...

en | US58933Y1055 | MERCK & CO. | boerse | 70142638 | bgmi